Related Experiment Video
Updated: Dec 22, 2025

The Adventures of Fundi Intervention Based on the Cognitive and Emotional Processing in Attention Deficit Hyperactive Disorder Patients
Published on: June 12, 2020
Management of Hyperactive Delirium in the Pediatric Intensive Care Unit: Case Series of Three Young Children
Anna O Jesus1, Lotte Jones2, Rebecca Linares3
1Division of Neurodevelopmental and Behavioral Pediatrics, University of Virginia, Charlottesville, Virginia, United States.
Insights
Pediatric intensive care unit (ICU) delirium can be serious. Atypical antipsychotics, though not FDA-approved for this use, were successfully used in short courses to treat three children with severe hyperactive delirium.
Area of Science:
- Pediatric critical care medicine
- Neuroscience
- Pharmacology
Background:
- Children in the intensive care unit (ICU) face a high risk of delirium due to illness, treatments, and the ICU environment.
- Delirium in critically ill children can lead to severe complications.
- Non-pharmacologic interventions are the first line of treatment, but may be insufficient.
Observation:
- Three pediatric patients in the ICU presented with hyperactive delirium.
- These patients were at risk for life-threatening complications due to their delirium.
- Standard treatments for delirium were considered unsuccessful or insufficient for these cases.
Findings:
- A short course of atypical antipsychotic medications was administered to the three pediatric patients.
- The atypical antipsychotics were effective in treating the hyperactive ICU delirium.
- No significant adverse side effects were reported during the short treatment courses.
Implications:
- Atypical antipsychotics may be a viable treatment option for severe pediatric ICU delirium when other methods fail.
- Further research is warranted to establish the safety and efficacy of atypical antipsychotics for pediatric delirium.
- This case report highlights a potential therapeutic strategy for a challenging clinical problem in pediatric critical care.
Abstract:
Children in the intensive care unit (ICU) are at high risk of developing delirium, given their underlying disease processes, the adverse effects of treatments and medications, and the stressful, abnormal environment. If prevention and nonpharmacologic measures to treat delirium are unsuccessful, atypical antipsychotics are considered, although they are not approved by Food and Drug Administration for the treatment of pediatric delirium and could have significant adverse side effects. This case report presents three pediatric patients with hyperactive ICU delirium that risked life-threating complications who were successfully treated with short courses of atypical antipsychotic medications.
Related Concept Videos
Attention-Deficit/Hyperactivity Disorder
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
Pharmacokinetics in Pediatric Patients: Drug Excretion
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Drug Dosing: Infants and Children
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Pharmacokinetics in Pediatric Patients: Drug Distribution

